The final trials of Oxford and AstraZeneca vaccine have been resumed after a brief pause.
The phase three testing of the COVID-19 vaccine being developed by Oxford University was put on hold in UK after a person experienced an adverse reaction. It has now received confirmation from an independent committee that it was safe to resume the trials. However, it is not known whether trials of the vaccine in other parts of the world will also resume.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.